Concepedia

Publication | Open Access

Efficacy and Safety of a Novel ĸ-Agonist for Managing Intractable Pruritus in Dialysis Patients

DOIFull Paper Access

152

Citations

12

References

2012

Year

Hiroo Kumagai, Toshiya Ebata, Kenji Takamori, K Miyasato, Taro Muramatsu, Hidetomo Nakamoto, Masanao Kurihara, Tomoji Yanagita, Hiromichi Suzuki
American Journal of Nephrology

Abstract

Nalfurafine hydrochloride, orally administered at 5 µg/day for 52 weeks to hemodialysis patients, produced a long-term suppression of pruritus without significant safety problems.

References

YearCitations

Page 1